Growth Metrics

Q32 Bio (QTTB) Return on Invested Capital (2022 - 2025)

Historic Return on Invested Capital for Q32 Bio (QTTB) over the last 4 years, with Q2 2025 value amounting to 20.44%.

  • Q32 Bio's Return on Invested Capital rose 220000.0% to 20.44% in Q2 2025 from the same period last year, while for Jun 2025 it was 20.44%, marking a year-over-year increase of 220000.0%. This contributed to the annual value of 0.76% for FY2024, which is 231200.0% down from last year.
  • Per Q32 Bio's latest filing, its Return on Invested Capital stood at 20.44% for Q2 2025, which was up 220000.0% from 13.48% recorded in Q1 2025.
  • In the past 5 years, Q32 Bio's Return on Invested Capital ranged from a high of 20.44% in Q2 2025 and a low of 13.48% during Q1 2025
  • In the last 4 years, Q32 Bio's Return on Invested Capital had a median value of 0.06% in 2022 and averaged 0.37%.
  • Within the past 5 years, the most significant YoY rise in Q32 Bio's Return on Invested Capital was 220000bps (2025), while the steepest drop was -143500bps (2025).
  • Over the past 4 years, Q32 Bio's Return on Invested Capital (Quarter) stood at 0.85% in 2022, then plummeted by -66bps to 0.29% in 2023, then plummeted by -1712bps to 4.62% in 2024, then surged by 542bps to 20.44% in 2025.
  • Its Return on Invested Capital was 20.44% in Q2 2025, compared to 13.48% in Q1 2025 and 4.62% in Q4 2024.